Zaiding Pharmaceutical's net revenue for the third quarter was 102 million US dollars, a year-on-year increase of 47%
阿豆学长长ov
发表于 2024-11-13 10:17:37
136
0
0
Caizhong News Agency, November 13th - Zaiding Pharmaceutical (09688/ZLAB) released its third quarter report as of September 30, 2024. In the third quarter of 2024, the company's net product revenue was $102 million, a year-on-year increase of 47%, mainly due to the sales growth of Weiweijia, Zele, and Nuozaile. Among them, Wei Weijia's income was 27.3 million US dollars, while the income of Ze Le and Niu Zaile were 48.2 million US dollars and 10 million US dollars respectively. R&D expenses amounted to $66 million, sales, general and administrative expenses amounted to $67.2 million, operating losses amounted to $67.9 million, net losses amounted to $41.7 million, and a loss of $0.04 per common share.
As of September 30, 2024, the company's cash reserves were $716 million, a decrease from $730 million as of June 30, 2024.
Recently, KarXT has achieved positive results in bridging research for schizophrenia in China, and is expected to submit a marketing authorization application in early 2025. In addition, ZL-1310 has shown promising potential in the global phase 1 study of small cell lung cancer, and it is expected that three products will be commercially launched in China by the end of 2024. The company is continuously advancing its innovative drug pipeline, demonstrating promising market prospects.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Selling more and losing more? NIO's third quarter revenue decreased by 2.1% year-on-year, with an adjusted net loss of 4.413 billion yuan
- Manbang Group's third quarter revenue and net profit both hit a new high, continuing to help small and medium-sized enterprises reduce costs and increase efficiency
- Jiayin Technology Third Quarter Report: Promoted transaction amount of 26.7 billion yuan, a year-on-year increase of 10.3%
- Baidu achieved a revenue of 33.6 billion yuan in the third quarter, and the daily average call volume of the Wenxin big model reached 1.5 billion times
- Baidu's third quarter revenue reached 33.6 billion yuan, while non online marketing revenue increased by 12%
- Continuously exploring excellent health industry supply chains, gathering third quarter revenue of 88.6 million yuan
- Baidu's third quarter performance is filled with long-term AI strategies
- Baidu's net profit increased by 14% in the third quarter, and the Wenxin big model was called 1.5 billion times a day
- IQIYI's membership and advertising revenue experienced a double-digit decline in the third quarter, with increased efforts to attract new members through micro dramas
- Pinduoduo's net profit in the third quarter declined month on month: fierce competition and slowing growth are inevitable trends, prepare for a long-term battle
-
11月21日、2024世界インターネット大会烏鎮サミットで、創業者、CEOの周源氏が大会デジタル教育フォーラムとインターネット企業家フォーラムでそれぞれ講演、発言したことを知っている。周源氏によると、デジタル教 ...
- 不正经的工程师
- 昨天 16:36
- 支持
- 反对
- 回复
- 收藏
-
アリババは、26億5000万ドルのドル建て優先無担保手形と170億元の人民元建て優先無担保手形の定価を発表した。ドル債の発行は2024年11月26日に終了する予定です。人民元債券の発行は2024年11月28日に終了する予定だ ...
- SOGO
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
スターバックスが中国事業の株式売却の可能性を検討していることが明らかになった。 11月21日、外国メディアによると、スターバックスは中国事業の株式売却を検討している。関係者によると、スターバックスは中国事 ...
- 献世八宝掌
- 前天 16:29
- 支持
- 反对
- 回复
- 收藏
-
【意法半導体CEO:中国市場は非常に重要で華虹と協力を展開】北京時間11月21日、意法半導体(STM.N)は投資家活動の現場で、同社が中国ウェハー代工場の華虹公司(688347.SH)と協力していると発表した。伊仏半導体 ...
- 黄俊琼
- 前天 14:29
- 支持
- 反对
- 回复
- 收藏